Home

QUEST DIAGNOSTICS INC

CIK 1022079 · last filed 2011-05-10

QUEST DIAGNOSTICS INC is a corporate insider who has filed 2 SEC Form 4 insider transactions across 2 companies since 2007. The most recent filing shows the insider bought $13.7M of CRA on May 10, 2011. Across all open-market trades the lifetime net is +$13.7M, making them a net buyer over the disclosed history. The firm reports its address in Secaucus, NJ. 127 SEC filings were submitted jointly with MICHAEL E PREVOZNIK.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

2

Total Filings

2

Lifetime Open-Market Net

$13.70M

Filer Profile

Reported Address
500 PLAZA DRIVE
SECAUCUS, NJ 07094
Phone
(973) 520-2700
State of Incorporation
DE
Formerly Known As
CORNING CLINICAL LABORATORIES INC (1996–1997)
Related Filers
MICHAEL E PREVOZNIK — 127 joint filings, latest 2026-08-31
Catherine T. Doherty — 93 joint filings, latest 2026-03-06
TIMOTHY M RING — 73 joint filings, latest 2026-05-21
J. E. Davis — 63 joint filings, latest 2026-09-03
ROBERT HAGEMANN — 61 joint filings, latest 2013-03-07
STEPHEN H RUSCKOWSKI — 58 joint filings, latest 2023-03-08
THOMAS F BONGIORNO — 56 joint filings, latest 2015-03-03
KENNETH W/NJ FREEMAN — 56 joint filings, latest 2004-12-14
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Celera CORP (CRA) Delisted 10%+ Owner 51,722,734 — — $13.70M 1 2011-05-10
Aspira Women's Health Inc. (VRML) Delisted 10%+ Owner 8,605,952 — — $0 1 2007-08-28

Recent Filings

2 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2011-05-10 Celera CORP (CRA) Delisted Buy (P) +1,712,202 $13.70M EDGAR
2007-08-28 Aspira Women's Health Inc. (VRML) Delisted Mixed +2,380,952 $1.76M EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.